Esophageal Intramural Pseudodiverticulosis and Concomitant Eosinophilic Esophagitis: A Case Series
Table 2
The clinical course, therapeutic interventions, and outcomes for all patients, including subgroup analysis of patients with EIPD and with EoE and pseudodiverticulosis.
Characteristics
All patients ()
Patients with EIPD ()
Patients with EoE and pseudodiverticulosis ()
value
Total duration of follow-up (months), mean (SD)
44.4 (38.1)
52.2 (42.6)
27.8 (20.0)
0.360
Endoscopic treatment
Dilatation (balloon, bougienage), (%)
9 (56.3)
7 (63.6)
2 (40.0)
0.596
Balloon dilatation, (%)
1 (6.3)
1 (9.1)
0 (0)
NS
Bougienage, (%)
7 (43.8)
6 (54.5)
1 (20.0)
0.308
Total number of endoscopic dilatations, mean (SD)
2.7 (2.5)
1.67 (1.2)
3.0 (2.8)
0.643
Mortality
Deaths, (%)
1 (6.3)
1 (9.1)
0 (0)
NS
EIPD: esophageal intramural pseudodiverticulosis; EoE: eosinophilic esophagitis; SD: standard deviation; NS: not significant. Mean value calculated only for patients receiving endoscopic dilatations.
